Study Assessing Impact of Dermatology Consultation for Patients Admitted With Cellulitis
| Status: | Recruiting |
|---|---|
| Conditions: | Cosmetic |
| Therapuetic Areas: | Dermatology / Plastic Surgery |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 4/2/2016 |
| Start Date: | October 2012 |
| Contact: | Daniela Kroshinsky, MD |
| Email: | dkroshinsky@partners.org |
| Phone: | 617-643-3884 |
A Randomized Controlled Study to Assess the Impact of Dermatology Consultations on the Hospital Course of Patients Admitted for Cellulitis
This is a randomized, controlled study to compare patients evaluated and managed by internal
medicine hospitalists alone versus patients who are additionally evaluated by a
dermatologist when they are admitted to the hospital, aiming to demonstrate that hospital
admissions for cellulitis that involve early dermatology consultation will reduce hospital
length of stay, readmission rates, prevalence of pseudocellulitis, cost, and antibiotic
usage. The hypothesis of this study is that obtaining inpatient dermatology consultations,
within 24 hours of a patient being admitted to the hospital for cellulitis, will reduce the
length of stay, readmission rate, cost, and antibiotic usage of the patient‟s admission as
well as properly evaluate and diagnose patients with pseudocellulitis. The primary objective
will be to measure the difference in the length of stay for patients who are randomized to a
dermatology consultation within 24 hours of hospital admission (active arm) versus being
managed by an internal medicine hospitalist alone, as is the standard of care (control arm).
The length of stay for each arm will be assessed once the study has been completed. The
secondary endpoint will be to measure readmission rates for cellulitis after patients are
discharged from the hospital. An additional endpoint will be to determine if antibiotic
usage differs between patients randomized to a dermatology consultation and those not.
Exploratory analyses will assess the percentage of patients with a concomitant known
predisposing factor for recurrent cellulitis such as lymphedema, leg ulceration, tinea
pedis, or onychomycosis, as well as the association of fever >100.5 F and a history of a
prior episode of cellulitis.
medicine hospitalists alone versus patients who are additionally evaluated by a
dermatologist when they are admitted to the hospital, aiming to demonstrate that hospital
admissions for cellulitis that involve early dermatology consultation will reduce hospital
length of stay, readmission rates, prevalence of pseudocellulitis, cost, and antibiotic
usage. The hypothesis of this study is that obtaining inpatient dermatology consultations,
within 24 hours of a patient being admitted to the hospital for cellulitis, will reduce the
length of stay, readmission rate, cost, and antibiotic usage of the patient‟s admission as
well as properly evaluate and diagnose patients with pseudocellulitis. The primary objective
will be to measure the difference in the length of stay for patients who are randomized to a
dermatology consultation within 24 hours of hospital admission (active arm) versus being
managed by an internal medicine hospitalist alone, as is the standard of care (control arm).
The length of stay for each arm will be assessed once the study has been completed. The
secondary endpoint will be to measure readmission rates for cellulitis after patients are
discharged from the hospital. An additional endpoint will be to determine if antibiotic
usage differs between patients randomized to a dermatology consultation and those not.
Exploratory analyses will assess the percentage of patients with a concomitant known
predisposing factor for recurrent cellulitis such as lymphedema, leg ulceration, tinea
pedis, or onychomycosis, as well as the association of fever >100.5 F and a history of a
prior episode of cellulitis.
Inclusion Criteria:
- Able to understand and sign informed consent
- Able to complete study and comply with study procedures
- Presumed clinical diagnosis of cellulitis by medicine team
Exclusion Criteria:
- Have a known postoperative site infection or abscess
- Have a human/animal bite
- Have known osteomyelitis
- Have a hardware/line infection
- Are under the age of 18
- Have a history of transplantation less than six months after initial transplant
and/or if they have had an episode of acute rejection in the last 90 days
- Known use of antithymocyte globulin or campath in the last 6 months or more than 20
mg/day of prednisone for more than 30 days -
- Are a known prisoner.
- Are decisionally-impaired.
- Have abnormal vital signs defined as systolic blood pressure <90 mmHg, diastolic
blood pressure <80 mmHg, heart rate greater than 90 beats per minute or less than 50
beats per minute, respiratory rate greater than 20, or temperature > 100.5 F.
- Are known to be pregnant.
We found this trial at
1
site
Click here to add this to my saved trials
